• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用气液色谱法和电子捕获检测法测定血浆中的硝苯地平。

Measurement of nifedipine in plasma by gas--liquid chromatography and electron-capture detection.

作者信息

Hamann S R, McAllister R G

出版信息

Clin Chem. 1983 Jan;29(1):158-60.

PMID:6848253
Abstract

In this method for measuring nifedipine, a calcium-channel inhibitor now widely used in the treatment of cardiovascular disease, the drug is extracted from plasma under basic conditions into toluene, and an aliquot of the extract is injected directly into a gas chromatograph equipped with an OV-101 column and an electron-capture detector. The standard curve is linear between 1 and 100 micrograms/L; the assay measures not only nifedipine, but also a major metabolic product (found only after oral administration of the parent drug) and photodegradation products. The procedure is rapid and adequately sensitive for routine use in clinical monitoring of nifedipine in plasma.

摘要

在这种用于测定硝苯地平(一种目前广泛用于治疗心血管疾病的钙通道抑制剂)的方法中,该药物在碱性条件下从血浆中萃取到甲苯中,然后取一份萃取液直接注入配备有OV - 101柱和电子捕获检测器的气相色谱仪中。标准曲线在1至100微克/升之间呈线性;该测定法不仅能检测硝苯地平,还能检测一种主要代谢产物(仅在口服母体药物后才会出现)和光降解产物。该方法快速且灵敏度足以用于血浆中硝苯地平临床监测的常规检测。

相似文献

1
Measurement of nifedipine in plasma by gas--liquid chromatography and electron-capture detection.采用气液色谱法和电子捕获检测法测定血浆中的硝苯地平。
Clin Chem. 1983 Jan;29(1):158-60.
2
Simultaneous determination of nitrendipine and one of its metabolites in plasma samples by gas chromatography with electron-capture detection.
J Pharm Biomed Anal. 2007 Jul 27;44(3):674-9. doi: 10.1016/j.jpba.2006.06.045. Epub 2006 Aug 22.
3
[Determination of nifedipine in human plasma by gas chromatography and its pharmacokinetic study].[气相色谱法测定人血浆中硝苯地平及其药代动力学研究]
Yao Xue Xue Bao. 1997;32(2):147-50.
4
Determination of nifedipine in serum or plasma by reversed-phase liquid chromatography.
Clin Chem. 1983 Jul;29(7):1344-8.
5
Gas chromatographic method for the quantification of the new calcium antagonist benidipine hydrochloride in plasma using electron capture detection.
Arzneimittelforschung. 1988 Nov;38(11A):1730-3.
6
Determination of nifedipine in human plasma by capillary gas chromatography with nitrogen detection.采用带氮检测的毛细管气相色谱法测定人血浆中的硝苯地平。
J Chromatogr. 1983 Nov 25;279:675-80. doi: 10.1016/s0021-9673(01)93672-6.
7
Determination of nifedipine in plasma by a rapid capillary gas chromatographic method.
Biomed Chromatogr. 1992 Jan-Feb;6(1):20-3. doi: 10.1002/bmc.1130060107.
8
Determination of nifedipine in human plasma by high-performance liquid chromatography with electrochemical detection.
J Chromatogr. 1985 Jun 14;341(2):341-7. doi: 10.1016/s0378-4347(00)84047-5.
9
Gas chromatographic determination of nifedipine and one of its metabolites using electron capture detection.
J Chromatogr. 1979 Jan 1;162(1):81-7. doi: 10.1016/s0378-4347(00)82066-6.
10
Occurrence and measurement of nifedipine and its nitropyridine derivatives in human blood plasma.
J Chromatogr. 1982 Sep 10;231(2):451-8. doi: 10.1016/s0378-4347(00)81871-x.

引用本文的文献

1
Effect of nifedipine on mouth-to-cecum transit of liquid meal in normal subjects.硝苯地平对正常受试者液体餐从口腔至盲肠转运时间的影响。
Dig Dis Sci. 1993 Jun;38(6):1022-5. doi: 10.1007/BF01295716.
2
Comparison of effects of nifedipine, propantheline bromide, and the combination on esophageal motor function in normal volunteers.
Dig Dis Sci. 1984 Apr;29(4):300-4. doi: 10.1007/BF01318513.
3
The pharmacodynamics and pharmacokinetics of a new calcium antagonist nisoldipine in normotensive and hypertensive subjects.新型钙拮抗剂尼索地平在血压正常和高血压受试者中的药效学和药代动力学。
Eur J Clin Pharmacol. 1985;29(1):21-4. doi: 10.1007/BF00547363.
4
Effect of nifedipine on gastric emptying in normal subjects.硝苯地平对正常受试者胃排空的影响。
Dig Dis Sci. 1985 Aug;30(8):710-2. doi: 10.1007/BF01320483.
5
Non-bioequivalence of sublingual nifedipine.舌下含服硝苯地平的非生物等效性。
Br J Clin Pharmacol. 1987 May;23(5):589-90. doi: 10.1111/j.1365-2125.1987.tb03096.x.
6
Nifedipine. Relationship between pharmacokinetics and pharmacodynamics.硝苯地平。药代动力学与药效学之间的关系。
Clin Pharmacokinet. 1987 Jan;12(1):12-29. doi: 10.2165/00003088-198712010-00002.
7
Complexation of nifedipine with substituted phenolic ligands.
Pharm Res. 1988 Oct;5(10):655-9. doi: 10.1023/a:1015979021590.
8
Influence of nifedipine therapy on indocyanine green and oral propranolol pharmacokinetics.硝苯地平治疗对吲哚菁绿和口服普萘洛尔药代动力学的影响。
Eur J Clin Pharmacol. 1989;37(3):257-60. doi: 10.1007/BF00679780.
9
Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.硝苯地平。对其在缺血性心脏病、高血压及相关心血管疾病中的药效学、药代动力学特性及治疗效果的综述。
Drugs. 1985 Sep;30(3):182-274. doi: 10.2165/00003495-198530030-00002.
10
Sustained release nifedipine formulations. An appraisal of their current uses and prospective roles in the treatment of hypertension, ischaemic heart disease and peripheral vascular disorders.硝苯地平缓释制剂。对其在高血压、缺血性心脏病和周围血管疾病治疗中的当前用途及未来作用的评估。
Drugs. 1991 May;41(5):737-79. doi: 10.2165/00003495-199141050-00006.